MacEdo, M. F., Quinta, R., Pereira, C. S., & Sa Miranda, M. C. (2012). Enzyme replacement therapy partially prevents invariant Natural Killer T cell deficiency in the Fabry disease mouse model. Molecular Genetics and Metabolism, 106(1), 83 - 91.

Hollak, C. E. M., vom Dahl, S., Aerts, J. M. F. G., Belmatoug, N., et al. (2010). Force Majeure: Therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease. Blood Cells, Molecules, and Diseases, 44(1), 41 - 47.